2020
DOI: 10.1152/ajpendo.00466.2019
|View full text |Cite
|
Sign up to set email alerts
|

The kinetics of glucagon action on the liver during insulin-induced hypoglycemia

Abstract: Glucagon’s effect on hepatic glucose production (HGP), under hyperglycemic conditions, is time dependent such that after an initial burst of HGP, it slowly wanes. It is not known whether this is also the case under hypoglycemic conditions, where an increase in HGP is essential. This question was addressed using adrenalectomized dogs to avoid the confounding effects of other counterregulatory hormones. During the study, infusions of epinephrine and cortisol were given to maintain basal levels. Somatostatin and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 55 publications
0
2
0
Order By: Relevance
“…Glucagon upregulates glutaminase, the enzyme that deaminates glutamine into glutamate and ammonium ( 41 ), supporting our findings of a negative association between glucagon and glutamine. Further, glucagon increases glutamine uptake in the liver ( 42 , 43 ). Finally, the observed negative association between glucagon and glycine has previously been explained by glucagon-induced upregulation of the glycine cleavage system ( 44 , 45 , 46 ).…”
Section: Discussionmentioning
confidence: 99%
“…Glucagon upregulates glutaminase, the enzyme that deaminates glutamine into glutamate and ammonium ( 41 ), supporting our findings of a negative association between glucagon and glutamine. Further, glucagon increases glutamine uptake in the liver ( 42 , 43 ). Finally, the observed negative association between glucagon and glycine has previously been explained by glucagon-induced upregulation of the glycine cleavage system ( 44 , 45 , 46 ).…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, following a minimally invasive protocol, we did not quantify circulating glucoregulatory hormones. However, it is known that ingesting protein or amino acids increases plasma glucagon concentration (13) and such increases in glucagon will be associated with a counter reduced catecholamine response (11) even during hypoglycemia (33). Therefore, the metabolic outcome of ingesting the protein supplement in the current study is likely owing to both an increase in plasma glucagon and decrease in catecholamine concentrations.…”
Section: Discussionmentioning
confidence: 99%